FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients

Jeremy McGale1, Sakshi Khurana1, Harrison Howell1

  • 1From the Department of Radiology, New York-Presbyterian Hospital, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

PubMed

Insights

Fibroblast activation protein (FAP)-targeted imaging shows promise for early breast cancer detection and monitoring. This approach enhances personalized treatment strategies, aiming for better patient outcomes in breast cancer care.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Radiochemistry

Background:

  • Breast cancer is a major global health concern requiring advanced diagnostics and treatments.
  • Cancer-associated fibroblasts expressing fibroblast activation proteins (FAPs) are key targets in breast tumors.
  • FAP-targeted molecular imaging offers potential for improved breast cancer management.

Purpose of the Study:

  • To review the role of FAP-targeted molecular imaging in breast cancer.
  • To explore advancements in FAP protein assessment and targeted therapies.
  • To highlight emerging applications of FAP-targeted imaging.

Main Methods:

  • Review of current literature on FAP-targeted imaging techniques.
  • Analysis of FAP-specific radiotracers for PET/CT and SPECT/CT.
  • Exploration of protein status assessment and early-phase targeted therapy development.

Main Results:

  • FAP-targeted imaging can aid in early detection, staging, and treatment response monitoring of breast cancer.
  • Development of FAP-specific radiotracers is crucial for effective molecular imaging.
  • Emerging applications show potential for personalized oncologic care.

Conclusions:

  • FAP-targeted imaging represents a significant advancement in breast cancer diagnostics and therapeutics.
  • This approach can lead to enhanced personalized oncologic care and improved patient outcomes.
  • Continued innovation in FAP-targeted strategies is vital for future breast cancer management.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
81
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
82